The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Gut–Liver Axis in Alcoholic Liver Disease
Open accessAbstract
Alcoholic liver disease (ALD) has been among the leading causes of cirrhosis and liver-related death worldwide for decades. Early discoveries in alcoholic liver disease identified increased levels of bacterial endotoxin in the portal circulation, suggesting a role for gut-derived toxins in ALD. Indeed, alcohol consumption can disrupt the intestinal epithelial barrier and result in increased gut permeability that increasingly is recognized as a major factor in ALD. Bacterial endotoxin, lipopolysaccharide, is a prototypic microbe-derived inflammatory signal that contributes to inflammation in ALD through activation of the Toll-like receptor 4. Recent studies also have shown that alcohol consumption is associated with alterations in the gut microbiome, and the dysbalance of pathogenic and commensal organisms in the intestinal microbiome may contribute to the abnormal gut-liver axis in ALD. Indeed, bacterial decontamination improves ALD both in human and animal models. This short review summarizes recent findings and highlights emerging trends in the gut-liver axis relevant to ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the gut-liver axis has been shown to play an important role in the development of ALD.5,6”
From Opposite regulation of intestinal and intrahepatic CD8 + T cells controls alcohol-associated liver disease progression (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“A number of functional studies have shown a key contribution of the gut-microbiota–TLR4 axis to ALD45:”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,996
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Cited by
Sorted by citations
Items 201–300 of 754
Microbiota-Dependent Effects of IL-22
Sabihi, M., Böttcher, M., Pelczar, P., & Huber, S. (2020) · Cells · doi:10.3390/cells9102205 · Cited by 52
Wu, Z., Liu, X., Huang, S., Li, T., Zhang, X., Pang, J., Zhao, J., Chen, L., Zhang, B., Wang, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.865273 · Cited by 51
Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease
Shen, H., Liangpunsakul, S., Iwakiri, Y., Szabó, G., & Wang, H. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01291-w · Cited by 49
Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis
Wong, V. W., & Singal, A. K. (2019) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2019.06.06 · Cited by 45
Edible plant-derived nanotherapeutics and nanocarriers: recent progress and future directions
Chen, N., Sun, J., Zhu, Z., Cribbs, A. P., & Xiao, B. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2053673 · Cited by 46
Folic acid ameliorates alcohol-induced liver injury via gut–liver axis homeostasis
Zhang, H., Zuo, Y., Zhao, H., Zhao, H. J., Wang, Y., Zhang, X., Zhang, J., Wang, P., Sun, L., Zhang, H., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.989311 · Cited by 46
Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong, M., Han, D. H., Hong, J., Kim, D. J., & Suk, K. T. (2018) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-018-9419-6 · Cited by 44
Cheng, F., Zhang, Y., Li, Q., Zeng, F., & Wang, K. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2019.4607 · Cited by 45
Seitz, H. K., & Neuman, M. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040858 · Cited by 45
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Muynck, K. D., Vanderborght, B., Vlierberghe, H. V., & Devisscher, L. (2021) · Cells · doi:10.3390/cells10112959 · Cited by 48
Stearic acid prevent alcohol-induced liver damage by regulating the gut microbiota
Nie, W., Xu, F., Zhou, K., Yang, X., Zhou, H. M., & Xu, B. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111095 · Cited by 45
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Feng, D., Hwang, S., Guillot, A., Wang, Y., Guan, Y., Chen, C., Maccioni, L., & Gao, B. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.04.009 · Cited by 44
Singal, A. K., Kwo, P. Y., Kwong, A. J., Liangpunsakul, S., Louvet, A., Mandrekar, P., McClain, C. J., Mellinger, J. L., Szabó, G., Terrault, N. A., et al. (2021) · Hepatology · doi:10.1002/hep.32143 · Cited by 44
Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
You, M. S., Zhou, L., Wu, F., Zhang, L., Zhu, S.-X., & Zhang, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107694 · Cited by 53
Donnadieu‐Rigole, H., Pansu, N., Mura, T., Pelletier, S., Alarcon, R., Gamon, L., Perney, P., Apparailly, F., Lavigne, J., & Dunyach‐Remy, C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13527 · Cited by 44
Nyakundi, B. B., Tóth, A., Balogh, E., Nagy, B., Erdei, J., Ryffel, B., Paragh, G., Cordero, M. D., & Jeney, V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.030 · Cited by 45
Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice
Feng, R., Ma, L., Wang, M., Liu, C., Yang, R., Su, H., Yang, Y., & Wan, J. (2020) · Communications Biology · doi:10.1038/s42003-020-01213-8 · Cited by 45
Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999–2018
Yoon, Y., Chen, C. M., Slater, M. E., Jung, M. K., & White, A. M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.04.024 · Cited by 46
The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
Kanmani, P., Kanmani, S., & Kim, H. (2020) · Biomedicines · doi:10.3390/biomedicines8110501 · Cited by 44
Zhang, H., Hu, Q., Zhang, Y., Yang, L., Tian, S., Zhang, X., Shen, H., Shu, H., Xie, L., Wu, D., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2517821 · Cited by 43
Shen, T. D., Pyrsopoulos, N., & Rustgi, V. K. (2018) · Liver Transplantation · doi:10.1002/lt.25008 · Cited by 44
Ikejima, K., Kon, K., & Yamashina, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0202 · Cited by 41
Antimicrobial proteins: intestinal guards to protect against liver disease
Hendrikx, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1521-8 · Cited by 42
Xia, B., Wu, W., Zhang, L., Wen, X., Xie, J., & Zhang, H. (2021) · Food & Function · doi:10.1039/d1fo02582a · Cited by 43
Autism Spectrum Disorder and Fetal Alcohol Spectrum Disorder: A Literature Review
Carpita, B., Migli, L., Chiarantini, I., Battaglini, S., Montalbano, C., Carmassi, C., Cremone, I. M., & Dell’Osso, L. (2022) · Brain Sciences · doi:10.3390/brainsci12060792 · Cited by 48
Epigenetics of alcohol-related liver diseases
Habash, N. W., Sehrawat, T. S., Shah, V. H., & Cao, S. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100466 · Cited by 44
Dietary Goji Shapes the Gut Microbiota to Prevent the Liver Injury Induced by Acute Alcohol Intake
Guo, L., Guan, Q., Duan, W., Ren, Y., Zhang, X., Xu, H., Shi, J., Wang, F., Lu, R., Zhang, H., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.929776 · Cited by 41
Role of FOXO3a Transcription Factor in the Regulation of Liver Oxidative Injury
Jin, H. W., Zhang, L., He, J., Wu, M., Li, J., & Guo, J. (2022) · Antioxidants · doi:10.3390/antiox11122478 · Cited by 45
Song, J., Zhao, X., Bo, J., Lv, Z., Li, G., Chen, Y., Liang, J., Zhang, C., Xiaoyan, J., Liu, C., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117552 · Cited by 40
Li, Z., Zhao, J., Zhang, S., & Weinman, S. A. (2018) · Cell Death Discovery · doi:10.1038/s41420-017-0020-7 · Cited by 42
Regulation of Hepatic Inflammation via Macrophage Cell Death
Li, Z., & Weinman, S. A. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1670674 · Cited by 43
Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
Stice, C. P., Xia, H., & Wang, X. (2018) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2018.11.001 · Cited by 40
Multi-Omics Insights into Functional Alterations of the Liver in Insulin-Deficient Diabetes Mellitus
Backman, M., Flenkenthaler, F., Blutke, A., Dahlhoff, M., Ländström, E., Renner, S., Philippou‐Massier, J., Krebs, S., Rathkolb, B., Prehn, C. P., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.011 · Cited by 41
The gut mycobiome: a novel player in chronic liver diseases
Jiang, L., Stärkel, P., Fan, J., Fouts, D. E., Bächer, P., & Schnabl, B. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01740-5 · Cited by 42
Kim, Y. S., Ko, B., Kim, D. J., Tak, J., Han, C. Y., Cho, J., Kim, W. K., & Kim, S. G. (2022) · Nature Communications · doi:10.1038/s41467-022-33749-0 · Cited by 41
Recent Advances in Gut‐ and Gut–Organ‐Axis‐on‐a‐Chip Models
Kim, R., & Sung, J. H. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202302777 · Cited by 43
Human immunodeficiency virus and liver disease: A comprehensive update
Sherman, K. E., Peters, M. G., & Thomas, D. L. (2017) · Hepatology Communications · doi:10.1002/hep4.1112 · Cited by 39
Zhang, Y., Jiang, M., Cui, B., Jin, C. H., Wu, Y., Shang, Y., Yang, H., Wu, M., Liu, J., Qiao, C., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15007 · Cited by 39
Jiang, L.-L., Hong, Y., Xiao, P., Wang, X., Zhang, J., Liu, E., Li, H., & Cai, Z. (2022) · Environmental Health Perspectives · doi:10.1289/ehp10281 · Cited by 38
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 40
Liu, X., Liu, M., Zhao, M., Li, P., Gao, C., Fan, X., Cai, G., Lu, Q., & Chen, X. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103109 · Cited by 41
Zhang, H., Li, C., Han, L., Xiao, Y., Bian, J., Liu, C., Gong, L., Liu, Z., & Wang, M. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2367342 · Cited by 39
Research Progress of Fecal Microbiota Transplantation in Liver Diseases
Zhao, Y., Chen, G., Xu, J., Chen, D., Yang, B., Chen, Z., & Wei, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041683 · Cited by 38
The role of IL‐22 in the resolution of sterile and nonsterile inflammation
Alabbas, S. Y., Begun, J., Florin, T. H., & Oancea, I. (2018) · Clinical & Translational Immunology · doi:10.1002/cti2.1017 · Cited by 37
“This ultimately leads to cirrhosis.(117) The initial hepatic injury is the result of oxidative and ER stress and mitochondrial damage induced by alcohol and its metabolites, leading to the activation of chemokines that stimulate macrophages, IL-8 and neutrophils.”
BackgroundImmunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
Yan, M., Man, S., Ma, L., Guo, L., Huang, L., & Gao, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0315 · Cited by 39
Yamada, K., Mizukoshi, E., Seike, T., Horii, R., Kitahara, M., Sunagozaka, H., Arai, K., Yamashita, T., Honda, M., & Kaneko, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191026 · Cited by 37
Posteraro, B., Sterbini, F. P., Petito, V., Rocca, S., Cubeddu, T., Graziani, C., Arena, V., Vassallo, G. A., Mosoni, C., Lopetuso, L. R., et al. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13900 · Cited by 37
Jung, F., Burger, K., Staltner, R., Brandt, A., Mueller, S., & Bergheim, I. (2021) · Nutrients · doi:10.3390/nu13051659 · Cited by 37
Intake of Bifidobacterium lactis Probio-M8 fermented milk protects against alcoholic liver disease
He, Q., Yang, C., Kang, X., Chen, Y., Zhang, T., Zhang, H., & Kwok, L. (2022) · Journal of Dairy Science · doi:10.3168/jds.2021-21265 · Cited by 37
Philips, C. A., Ahamed, R., Rajesh, S., Singh, S. P., Tharakan, A. K., Abduljaleel, J. K., & Augustine, P. (2022) · Gastroenterology report · doi:10.1093/gastro/goac074 · Cited by 38
Harnessing the potential of probiotics in the treatment of alcoholic liver disorders
Mishra, G., Singh, P. N. D., Molla, M., Yimer, Y. S., Dinda, S. C., Chandra, P., Singh, B. K., Dagnew, S. B., Assefa, A. N., & Ewunetie, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1212742 · Cited by 39
Zhao, H., Zhang, Y., Hou, L., Lu, H., Zhang, Y., & Xing, M. (2023) · Aquatic Toxicology · doi:10.1016/j.aquatox.2023.106760 · Cited by 36
Vatsalya, V., Song, M., Schwandt, M. L., Cave, M. C., Barve, S. S., George, D. T., Ramchandani, V. A., & McClain, C. J. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13197 · Cited by 37
Karoly, H. C., Mueller, R. L., Bidwell, L. C., & Hutchison, K. E. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14256 · Cited by 37
Interleukin-22 in alcoholic hepatitis and beyond
Xiang, X., Hwang, S., Feng, D., Shah, V. H., & Gao, B. (2020) · Hepatology International · doi:10.1007/s12072-020-10082-6 · Cited by 36
Yeh, W.-J., Tsai, C.-C., Ko, J., & Yang, H. (2020) · Nutrients · doi:10.3390/nu12123884 · Cited by 36
Xu, L., Huang, Q., Tan, X., Zhao, Q. L., Wu, J., Liao, H., Ai, W., Liu, Y., Lai, Z., & Fu, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107897 · Cited by 36
Xu, M.-Y., Guo, C.-C., Li, M., Lou, Y.-H., Chen, Z., Liu, B., & Lan, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1040749 · Cited by 35
Tao, M., Xie, Y., Fan, X., Yan, X., Fan, W., Cao, R., Li, M., Li, R., & Wang, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144719 · Cited by 35
Fang, C., Du, H., Zheng, X., Zhao, A., Jia, W. P., & Xu, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802306r · Cited by 38
Adipose tissue-liver axis in alcoholic liver disease
Wang, Z. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i1.17 · Cited by 35
Mitochondrial quality control in alcohol-associated liver disease
Thoudam, T., Gao, H., Jiang, Y., Huda, N., Yang, Z., Ma, J., & Liangpunsakul, S. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000534 · Cited by 34
Li, F., Zhao, C., Shao, T., Liu, Y., Gu, Z., Jiang, M., Li, H., Zhang, L., Gillevet, P. M., Puri, P., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5531 · Cited by 34
Shi, Y., Feng, R., Mao, J., Liu, S., Zhou, Z., Ji, Z., Chen, S., & Mao, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.689092 · Cited by 34
Gut non-bacterial microbiota contributing to alcohol-associated liver disease
Gao, W., Zhu, Y., Ye, J., & Chu, H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1984122 · Cited by 35
Alcohol Vapor Inhalation as a Model of Alcohol‐Induced Organ Disease
Mouton, A. J., Maxi, J. K., Souza‐Smith, F. M., Bagby, G. J., Gilpin, N. W., Molina, P. E., & Gardner, J. D. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13133 · Cited by 34
Combination therapy: New hope for alcoholic hepatitis?
Gao, B., & Shah, V. H. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.008 · Cited by 33
Crucial steps towards an effective treatment
Poelstra, K. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.224 · Cited by 33
Chopyk, D. M., Kumar, P., Raeman, R., Liu, Y., Smith, T., & Anania, F. A. (2017) · Physiological Reports · doi:10.14814/phy2.13541 · Cited by 33
Human microbiome is a diagnostic biomarker in hepatocellular carcinoma
Rao, B., Lou, J., Wang, W., Li, A., Cui, G., Yu, Z., & Ren, Z. (2020) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2020.01.003 · Cited by 35
Luo, L., Zhang, J., Liu, M., Qiu, S., Yi, S., Yu, W., Liu, T., Huang, X., & Ning, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673903 · Cited by 35
Targeting bile acid signaling for the treatment of liver diseases: From bench to bed
Duan, S., Li, X., Fan, G., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113154 · Cited by 33
Emerging Role of Edible Exosomes-Like Nanoparticles (ELNs) as Hepatoprotective Agents
Subudhi, P. D., Bihari, C., Sarin, S. K., & Baweja, S. (2022) · Nanotheranostics · doi:10.7150/ntno.70999 · Cited by 34
Gao, J.-H., Wen, S., Tong, H., Wang, C.-H., Yang, W.-J., Tang, S.-H., Yan, Z.-P., Tai, Y., Ye, C., Liu, R., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00428.2015 · Cited by 33
Gut Microbiota Regulation of AHR Signaling in Liver Disease
Wang, B., Zhou, Z., & Li, L. (2022) · Biomolecules · doi:10.3390/biom12091244 · Cited by 35
Wang, M., Zhang, X., Yan, C., He, C., Li, P., Chen, M., Su, H., & Wan, J. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.03.012 · Cited by 32
Fu, R., Zhou, J., Wang, R., Sun, R., Feng, D., Wang, Z., Zhao, Y., Lv, L., Tian, X., & Yao, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3527809 · Cited by 32
Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model
Huang, H., Lin, Z., Zeng, Y., Lin, X., & Zhang, Y. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8123 · Cited by 32
The Microbiome and Hepatocellular Carcinoma
Rattan, P., Minacapelli, C. D., & Rustgi, V. K. (2020) · Liver Transplantation · doi:10.1002/lt.25828 · Cited by 32
Zhong, W. H., Li, Q., Zhang, W., Sun, Q., Sun, X., & Zhou, Z. (2015) · Biomolecules · doi:10.3390/biom5042643 · Cited by 32
Lu, Y., Chen, W., Song, K., Han, C. L., Gandhi, C. R., Lim, K., & Wu, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176106 · Cited by 32
Protective Effect and Mechanism of Placenta Extract on Liver
Shen, L., Fan, L., Zhang, Y., Zhu, Y., Zong, X., Peng, G., & Cao, S. (2022) · Nutrients · doi:10.3390/nu14235071 · Cited by 37
Zhao, S., Zhang, Y., Ding, H., Hu, S., Wu, X., Ma, A., & Ma, Y. (2023) · Nutrients · doi:10.3390/nu15051229 · Cited by 33
Xiong, S.-Y., Wu, G.-S., Li, C., Ma, W., & Luo, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1358063 · Cited by 31
Virdee, M. S., Saini, N., Kay, C. D., Neilson, A. P., Kwan, S. T., Helfrich, K. K., Mooney, S. M., & Smith, S. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-80093-8 · Cited by 33
Bmal1 Regulates Macrophage Polarize Through Glycolytic Pathway in Alcoholic Liver Disease
Zhou, Y., Wu, M., Xu, L., Cheng, J., Shen, J., Yang, T., & Zhang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640521 · Cited by 30
Liu, S.-X., Liu, H., Wang, S., Zhang, C., Guo, F., & Zeng, T. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113108 · Cited by 31
Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease
Maccioni, L., Leclercq, I. A., Schnabl, B., & Stärkel, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312687 · Cited by 31
Gao, Y., Zhang, P., Wei, Y., Ye, C., Mao, D., Xia, D., & Luo, Y. (2023) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13833 · Cited by 30
Fang, C., Cheng, J., Jia, W. P., & Xu, Y. (2023) · Metabolites · doi:10.3390/metabo13101057 · Cited by 30
The Liver Microbiome Is Implicated in Cancer Prognosis and Modulated by Alcohol and Hepatitis B
Chakladar, J., Wong, L. M., Kuo, S. Z., Li, W. T., Yu, M. A., Chang, E. Y., Wang, X. Q., & Ongkeko, W. M. (2020) · Cancers · doi:10.3390/cancers12061642 · Cited by 30
Nie, W., Du, Y., Xu, F., Zhou, K., Wang, Z., Al‐Dalali, S., Wang, Y., Li, X., Ma, Y., Xie, Y., et al. (2021) · Food & Function · doi:10.1039/d1fo01693h · Cited by 30
Xia, T., Fang, B., Kang, C., Zhao, Y., Qiang, X., Zhang, X., Wang, Y., Zhong, T., Xiao, J., & Wang, M. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5025237 · Cited by 30
Fukui, H. (2016) · Cellular & Molecular Medicine Open access · doi:10.21767/2573-5365.100023 · Cited by 30
Bukong, T. N., Iracheta‐Vellve, A., Gyöngyösi, B., Ambade, A., Catalano, D., Kodys, K., & Szabó, G. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13096 · Cited by 29
Pan, Z., He, X., Song, N., Fang, D., Li, Z., Li, J., Luo, F., Li, J., Tan, H. S., & Fu, Q. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05599 · Cited by 29
Liu, Y., Liu, X., Wang, Y., Yi, C., Tian, J., Liu, K., & Chu, J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222339 · Cited by 29
Lamas‐Paz, A., Morán, L., Peng, J., Salinas, B., López‐Alcántara, N., Sydor, S., Vilchez‐Vargas, R., Asensio, I., Hao, F., Zheng, K., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603771 · Cited by 27
Yan, X., Ren, X., Liu, X., Wang, Y., Ma, J., Song, R., Wang, X., Dong, Y., Fan, Q., Wei, J., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02362 · Cited by 29
Li, D., Qian, H., Yang, H., Du, Y., Yu, K., Yang, J., Tong, X., Guo, Y., Xu, J., & Qin, L. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100253 · Cited by 29
Metadata
- Authors
- Szabo, G.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 148
- Issue
- 1
- Pages
- 30-36
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC4274189
- OpenAlex
- W2034801500
- Cited by
- 754
- References
- 81
- Citations by year
- 2026: 64 · 2025: 67 · 2024: 72 · 2023: 67 · 2022: 89 · 2021: 77 · 2020: 63 · 2019: 59 · 2018: 67 · 2017: 49 · 2016: 51 · 2015: 28
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA021907, AA017729, AA010744)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- alcoholic liver disease, gut-liver axis, bacterial endotoxin, lipopolysaccharide, intestinal permeability, intestinal epithelial barrier, TLR4, gut microbiota, bacterial decontamination, liver cirrhosis, inflammation
- MeSH terms
- Animals, Bacteria, Humans, Intestinal Mucosa, Intestines, Liver, Liver Diseases, Alcoholic, Permeability, Prognosis, Signal Transduction, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review